Paul M. Loadman
Bradford, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 68 publications
The relationship between elongation of very long-chain fatty acids (ELOVL) 2 polymorphism rs953413 and blood n-3 HUFA levels: a secondary analysis of EPA treatment in the seAFOod polyp prevention trial.
Journal: Genes & nutrition
Published: October 13, 2025
The Relationship Between Dietary and Supplemental omega-3 Highly Unsaturated Fatty Acid Intake, Blood and Tissue omega-3 Highly Unsaturated Fatty Acid Concentrations, and Colorectal Polyp Recurrence: A Secondary Analysis of the seAFOod Polyp Prevention Trial.
Journal: The Journal of nutrition
Published: August 14, 2024
Sidechain structure-activity relationships of cyclobutane-based small molecule αvβ3 antagonists.
Journal: RSC medicinal chemistry
Published: April 29, 2024
Hypoxia-Responsive Prodrug of ATR Inhibitor, AZD6738, Selectively Eradicates Treatment-Resistant Cancer Cells.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: April 11, 2024
Maleimide-Thiol Linkages Alter the Biodistribution of SN38 Therapeutic Microbubbles Compared to Biotin-Avidin While Preserving Parity in Tumoral Drug Delivery.
Journal: Pharmaceutics
Published: February 16, 2024
APOE genotype, eicosapentaenoic acid (EPA) supplementation and n-3 highly unsaturated fatty acid (HUFA) levels in patients with multiple colorectal polyps: A secondary analysis of the seAFOod polyp prevention trial.
Journal: Prostaglandins, leukotrienes, and essential fatty acids
Published: January 29, 2024
Randomised, placebo-controlled, phase 3 trial of the effect of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid (EPA) on colorectal cancer recurrence and survival after surgery for resectable liver metastases: EPA for Metastasis Trial 2 (EMT2) study protocol.
Journal: BMJ open
Published: November 29, 2023
The effect of aspirin and eicosapentaenoic acid on urinary biomarkers of prostaglandin E2 synthesis and platelet activation in participants of the seAFOod polyp prevention trial.
Journal: International journal of cancer
Published: August 04, 2023
Colorectal polyp outcomes after participation in the seAFOod polyp prevention trial: Evidence of rebound elevated colorectal polyp risk after short-term aspirin use.
Journal: Alimentary pharmacology & therapeutics
Published: May 08, 2023
Polymorphisms in Cyclooxygenase, Lipoxygenase, and TP53 Genes Predict Colorectal Polyp Risk Reduction by Aspirin in the seAFOod Polyp Prevention Trial.
Journal: Cancer prevention research (Philadelphia, Pa.)
Published: March 28, 2023
Plasma and rectal mucosal oxylipin levels during aspirin and eicosapentaenoic acid treatment in the seAFOod polyp prevention trial.
Journal: Prostaglandins, leukotrienes, and essential fatty acids
Published: December 12, 2022
Last Updated: 09/26/2026